Scholarlink

Aim <p>This scoping review synthesizes research on symptom clusters in colorectal cancer patients undergoing chemotherapy, identifying their types, assessment tools, and changes over time. The findings aim to guide future research and improve symptom management.</p> Methods <p>Following the Joanna Briggs Institute’s scoping review framework, a systematic search was conducted in PubMed, Embase, EBSCO (MEDLINE), Web of Science, Cochrane Library, CNKI, Wanfang, and VIP databases. The search period ranges from 2001 to December 25, 2024. Eligible studies underwent data extraction and synthesis.</p> Results <p>Nineteen studies met the inclusion criteria. A total of 34 symptom clusters were identified, categorized into psychological, gastrointestinal, neurotoxic, and other clusters. Eight assessment tools were used, with the MD Anderson Symptom Inventory being the most common. Longitudinal studies revealed significant variations in symptom clusters throughout chemotherapy, emphasizing the need for continuous monitoring and intervention.</p> Conclusion <p>The MD Anderson Symptom Inventory is widely used; however, consistent frameworks for naming and classifying the derived clusters are needed. A clearer understanding of symptom cluster dynamics is essential to inform targeted clinical interventions. Future research should focus on developing standardized classification approaches and examining the stability of symptom clusters over time to support improved symptom management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A scoping review of symptom clusters during chemotherapy in colorectal cancer patients

  • 期刊论文

  • 发表日期：

    2026年3月10日

查看全文
  • He Mingqian,
  • Ji Yue,
  • Fang Juan,
  • Yao Jinlan

摘要

Aim

This scoping review synthesizes research on symptom clusters in colorectal cancer patients undergoing chemotherapy, identifying their types, assessment tools, and changes over time. The findings aim to guide future research and improve symptom management.

Methods

Following the Joanna Briggs Institute’s scoping review framework, a systematic search was conducted in PubMed, Embase, EBSCO (MEDLINE), Web of Science, Cochrane Library, CNKI, Wanfang, and VIP databases. The search period ranges from 2001 to December 25, 2024. Eligible studies underwent data extraction and synthesis.

Results

Nineteen studies met the inclusion criteria. A total of 34 symptom clusters were identified, categorized into psychological, gastrointestinal, neurotoxic, and other clusters. Eight assessment tools were used, with the MD Anderson Symptom Inventory being the most common. Longitudinal studies revealed significant variations in symptom clusters throughout chemotherapy, emphasizing the need for continuous monitoring and intervention.

Conclusion

The MD Anderson Symptom Inventory is widely used; however, consistent frameworks for naming and classifying the derived clusters are needed. A clearer understanding of symptom cluster dynamics is essential to inform targeted clinical interventions. Future research should focus on developing standardized classification approaches and examining the stability of symptom clusters over time to support improved symptom management.